Status: Phase 2
Entry Type: Unknown
Molecule Category: UNKNOWN

Indications

Mesh Heading Maximum Phase Reference
Carcinoma, Non-Small-Cell Lung; Lung Neoplasms Phase 2 ClinicalTrials
Lymphoma Phase 2 ClinicalTrials
Multiple Myeloma; Neoplasms, Plasma Cell Phase 1/Phase 2 ClinicalTrials
Neoplasms Phase 1 ClinicalTrials
Breast Neoplasms Phase 2 ClinicalTrials
Gastrointestinal Stromal Tumors Phase 2 ClinicalTrials
Esophageal Neoplasms; Stomach Neoplasms Phase 1 ClinicalTrials
Myeloproliferative Disorders; Polycythemia; Polycythemia Vera; Primary Myelofibrosis; Thrombocythemia, Essential; Thrombocytosis Phase 2 ClinicalTrials
Stomach Neoplasms Phase 2 ClinicalTrials
Breast Neoplasms; Hematologic Neoplasms; Neoplasms Phase 1/Phase 2 ClinicalTrials
Carcinoma, Non-Small-Cell Lung; Lung Neoplasms Phase 2 ClinicalTrials
Carcinoma, Non-Small-Cell Lung; Lung Neoplasms Phase 1 ClinicalTrials
Carcinoma, Non-Small-Cell Lung; Lung Neoplasms Phase 2 ClinicalTrials
Adenocarcinoma; Neoplasm Metastasis Phase 2 ClinicalTrials
Adenocarcinoma; Colonic Neoplasms; Rectal Neoplasms Phase 1 ClinicalTrials
Breast Neoplasms Phase 1/Phase 2 ClinicalTrials
Carcinoma, Non-Small-Cell Lung; Lung Neoplasms Phase 2 ClinicalTrials
Gastrointestinal Stromal Tumors Phase 2 ClinicalTrials
Carcinoma, Non-Small-Cell Lung Phase 2 ClinicalTrials
CONTENTS